Dietary fiber enhances a tumor suppressor signaling pathway in the gut

Annals of Surgery

Volumn 243, Issue 5, 2006, Pages 619-625

  Nguyen, Khoa A ^a   Cao, Yanna ^a   Chen, Justin R ^a   Townsend Jr , Courtney M ^a   Ko, Tien C ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; CYCLOOXYGENASE 2; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN KINASE B; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; SMAD3 PROTEIN, HUMAN;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL TRANSFORMATION; CHEMOPROPHYLAXIS; COLON CANCER; DIETARY FIBER; GENE EXPRESSION; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; COLON TUMOR; CYTOLOGY; DRUG EFFECT; EPITHELIUM CELL; INTESTINE MUCOSA; METABOLISM; PHYSIOLOGY;

ANIMALS; BUTYRIC ACID; CELLS, CULTURED; COLONIC NEOPLASMS; DIETARY FIBER; EPITHELIAL CELLS; HUMANS; INTESTINAL MUCOSA; RATS; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 33746233585     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000216783.85214.c1     Document Type: Article

References (37)

1. Greenlee RT, Murray T, Bolden S, et al. Cancer statistics. CA Cancer J Clin. 2000;50:7-33.
2. Seifeldin R, Hantsch JJ. The economic burden associated with colon cancer in the United States. Clin Ther. 1999;21:1370-1379.
3. Burkitt DP. Related disease-related cause? Lancet. 1969;2:1229-1231.
4. Peters U, Sinha R, Chatterjee N, et al. Dietary fibre and colorectal adenoma in a colorectal cancer early detection programme. Lancet. 2003;361:1491-1495.
5. Bingham SA, Day NE, Luben R, et al. Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet. 2003;361:1496-1501.
6. Larsson SC, Giovannucci E, Bergkvist L, et al. Whole grain consumption and risk of colorectal cancer: a population-based cohort of 60,000 women. Br J Cancer. 2005;92:1803-1807.
7. D'Argenio G, Cosenza V, Delle CM, et al. Butyrate enemas in experimental colitis and protection against large bowel cancer in a rat model. Gastroenterology. 1996;110:1727-1734.
8. Kruh J. Effects of sodium butyrate, a new pharmacological agent, on cells in culture. Mol Cell Biochem. 1982;42:65-82.
9. Augeron C, Laboisse CL. Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate. Cancer Res. 1984;44:3961-3969.
10. Ko TC, Sheng HM, Reisman D, et al. Transforming growth factor-beta 1 inhibits cyclin D1 expression in intestinal epithelial cells. Oncogene. 1995;10:177-184.
11. Conery AR, Cao Y, Thompson EA, et al. Akt interacts directly with Smad3 to regulate the sensitivity to TGF-beta induced apoptosis. Nat Cell Biol. 2004;6:366-372.
12. Wang J, Han W, Zborowska E, et al. Reduced expression of transforming growth factor beta type I receptor contributes to the malignancy of human colon carcinoma cells. J Biol Chem. 1996;271:17366-17371.
13. Matsushita M, Matsuzaki K, Date M, et al. Down-regulation of TGF-beta receptors in human colorectal cancer: implications for cancer development. Br J Cancer. 1999;80:194-205.
14. Riggins GJ, Thiagalingam S, Rozenblum E, et al. Mad-related genes in the human. Nat Genet. 1996;13:347-349.
15. Eppert K, Scherer SW, Ozcelik H, et al. MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell. 1996;86:543-552.
16. Thiagalingam S, Lengauer C, Leach FS, et al. Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat Genet. 1996;13:343-346.
17. Takagi Y, Kohmura H, Futamura M, et al. Somatic alterations of the DPC4 gene in human colorectal cancers in vivo. Gastroenterology. 1996;111:1369-1372.
18. MacGrogan D, Pegram M, Slamon D, et al. Comparative mutational analysis of DPC4 (Smad4) in prostatic and colorectal carcinomas. Oncogene. 1997;15:1111-1114.
19. Heldin CH, Miyazono K, ten Dijke P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature. 1997;390:465-471.
20. Zhang Y, Derynck R. Regulation of Smad signalling by protein associations and signalling crosstalk. Trends Cell Biol. 1999;9:274-279.
21. Quaroni A, Wands J, Trelstad RL, et al. Epithelioid cell cultures from rat small intestine: characterization by morphologic and immunologic criteria. J Cell Biol. 1979;80:248-265.
22. Heid CA, Stevens J, Livak KJ, et al. Real time quantitative PCR. Genome Res. 1996;6:986-994.
23. Fakhari FD, Dittmer DP. Charting latency transcripts in Kaposi's sarcoma-associated herpesvirus by whole-genome real-time quantitative PCR. J Virol. 2002;76:6213-6223.
24. Sheng H, Shao J, DuBois RN. Akt/PKB activity is required for Ha-Ras-mediated transformation of intestinal epithelial cells. J Biol Chem. 2001;276:14498-14504.
25. McBain JA, Eastman A, Nobel CS, et al. Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors. Biochem Pharmacol. 1997;53:1357-1368.
26. Wang J, Friedman EA. Short-chain fatty acids induce cell cycle inhibitors in colonocytes. Gastroenterology. 1998;114:940-946.
27. Slivka SR, Loskutoff DJ. Platelets stimulate endothelial cells to synthesize type 1 plasminogen activator inhibitor: evaluation of the role of transforming growth factor beta. Blood. 1991;77:1013-1019.
28. Sheng H, Shao J, Hooton EB, et al. Cyclooxygenase-2 induction and transforming growth factor beta growth inhibition in rat intestinal epithelial cells. Cell Growth Differ. 1997;8:463-470.
29. Berger DH. Plasmin/plasminogen system in colorectal cancer. World J Surg. 2002;26:767-771.
30. Hague A, Manning AM, Hanlon KA, et al. Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: implications for the possible role of dietary fibre in the prevention of large-bowel cancer. Int J Cancer. 1993;55:498-505.
31. Heerdt BG, Houston MA, Augenlicht LH. Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines. Cancer Res. 1994;54:3288-3293.
32. Litvak DA, Evers BM, Hwang KO, et al. Butyrate-induced differentiation of Caco-2 cells is associated with apoptosis and early induction of p21Waf1/Cip1 and p27Kip1. Surgery. 1998;124:161-169.
33. Roman C, Saha D, Beauchamp RD. TGF-beta and colorectal carcinogenesis. Microsc Res Tech. 2001;52:450-457.
34. Derynck R, Goeddel DV, Ullrich A, et al. Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors. Cancer Res. 1987;47:707-712.
35. Robson H, Anderson E, James RD, et al. Transforming growth factor beta 1 expression in human colorectal tumours: an independent prognostic marker in a subgroup of poor prognosis patients. Br J Cancer. 1996;74:753-758.
36. Friedman E, Gold LI, Klimstra D, et al. High levels of transforming growth factor beta 1 correlate with disease progression in human colon cancer. Cancer Epidemiol Biomarkers Prev. 1995;4:549-554.
37. Steinbach G, Lynch PM, Phillips RK, et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med. 2000;342:1946-1952.